These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The advanced glycation end-product N epsilon-(carboxymethyl)lysine level is elevated in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Kaufmann E; Boehm BO; Süssmuth SD; Kientsch-Engel R; Sperfeld A; Ludolph AC; Tumani H Neurosci Lett; 2004 Nov; 371(2-3):226-9. PubMed ID: 15519762 [TBL] [Abstract][Full Text] [Related]
13. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis. Watanabe S; Kimura T; Suenaga K; Wada S; Tsuda K; Kasama S; Takaoka T; Kajiyama K; Takeda M; Yoshikawa H J Neurol Sci; 2009 Oct; 285(1-2):146-8. PubMed ID: 19595376 [TBL] [Abstract][Full Text] [Related]
14. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831 [TBL] [Abstract][Full Text] [Related]
15. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Roos PM; Vesterberg O; Syversen T; Flaten TP; Nordberg M Biol Trace Elem Res; 2013 Feb; 151(2):159-70. PubMed ID: 23225075 [TBL] [Abstract][Full Text] [Related]
16. Manganese in cerebrospinal fluid and blood plasma of patients with amyotrophic lateral sclerosis. Roos PM; Lierhagen S; Flaten TP; Syversen T; Vesterberg O; Nordberg M Exp Biol Med (Maywood); 2012 Jul; 237(7):803-10. PubMed ID: 22859739 [TBL] [Abstract][Full Text] [Related]
17. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases. Kapaki E; Segditsa J; Zournas C; Xenos D; Papageorgiou C Experientia; 1989 Dec; 45(11-12):1108-10. PubMed ID: 2599056 [TBL] [Abstract][Full Text] [Related]